Key Insights
The global Lab Automation in Genomics market is experiencing robust expansion, estimated at $2.12 billion in 2025 and projected to grow at a significant Compound Annual Growth Rate (CAGR) of 12.43% through 2033. This dynamic growth is primarily fueled by the increasing demand for high-throughput screening and precise genomic analysis across pharmaceutical research, biotechnology, and clinical diagnostics. Key drivers include the relentless pursuit of novel drug discovery, the burgeoning field of personalized medicine, and the growing need for efficient disease diagnosis and monitoring. The integration of artificial intelligence and machine learning is further accelerating innovation, enabling more sophisticated data analysis and workflow optimization within genomics laboratories. Companies are heavily investing in advanced automated solutions to enhance experimental reproducibility, reduce human error, and accelerate research timelines, thereby solidifying the market's upward trajectory.
Lab Automation in Genomics Industry Market Size (In Billion)
The market is segmented into several critical areas, with Automated Liquid Handlers and Automated Plate Handlers forming the backbone of many genomic workflows. Robotic Arms are increasingly employed for complex manipulation tasks, while Automated Storage and Retrieval Systems (AS/RS) are crucial for managing vast sample libraries. Vision Systems are vital for quality control and data acquisition. The competitive landscape is characterized by the presence of major global players like Becton Dickinson and Company, Tecan Group Ltd, Thermo Fisher Scientific Inc, and Danaher Corporation, who are continuously innovating to meet the evolving needs of researchers. North America currently holds a dominant market share due to significant R&D investments and the presence of leading life science companies. However, the Asia-Pacific region is anticipated to witness the fastest growth, driven by increasing healthcare expenditure, expanding research infrastructure, and growing adoption of advanced technologies.
Lab Automation in Genomics Industry Company Market Share
Unlocking Genomic Potential: A Comprehensive Report on Lab Automation in the Genomics Industry
This in-depth report provides a definitive analysis of the Lab Automation in Genomics Industry, a critical sector experiencing exponential growth fueled by advancements in high-throughput sequencing, personalized medicine, and the burgeoning demand for faster, more accurate genomic research and diagnostics. Spanning the Study Period of 2019–2033, with a Base Year of 2025 and a detailed Forecast Period of 2025–2033, this report offers unparalleled insights into market dynamics, technological innovations, and strategic opportunities for industry stakeholders. With a Historical Period of 2019–2024 covered, we provide a robust foundation for understanding current trends and projecting future trajectories. The global market for lab automation in genomics is projected to reach over $15 Million by 2033, driven by increasing research funding, the need for reduced turnaround times in diagnostics, and the growing complexity of genomic data analysis.
Lab Automation in Genomics Industry Market Concentration & Innovation
The Lab Automation in Genomics Industry exhibits a moderate to high level of market concentration, with a significant portion of the market share held by established global players. Key innovators continuously invest in research and development, driving advancements in precision, speed, and data integration. The market is characterized by intense competition, particularly in the realm of automated liquid handling and robotic sample processing. Innovation drivers include the increasing adoption of next-generation sequencing (NGS), the growing need for personalized therapeutics, and the rising prevalence of genetic diseases. Regulatory frameworks, such as those established by the FDA and EMA, play a crucial role in ensuring the safety, efficacy, and standardization of automated genomic workflows, indirectly fostering innovation by setting performance benchmarks. Product substitutes, while existing, often fall short in terms of throughput and accuracy, making dedicated lab automation solutions indispensable for large-scale genomic operations. End-user trends lean towards integrated, intelligent automation systems that can streamline entire workflows, from sample preparation to data analysis, reducing manual intervention and the potential for human error. Mergers and acquisitions (M&A) are a prominent feature, with significant M&A deal values reflecting the strategic importance of acquiring new technologies and expanding market reach. For instance, key M&A activities are anticipated to exceed $500 Million annually in the coming years.
- Market Share: Leading companies hold an estimated 70% of the total market share.
- M&A Deal Values: Expected to reach over $500 Million annually during the forecast period.
- Innovation Focus: High-throughput, AI-driven data integration, and miniaturization of robotic systems.
- Regulatory Impact: Increased demand for validated and compliant automation solutions.
Lab Automation in Genomics Industry Industry Trends & Insights
The Lab Automation in Genomics Industry is poised for robust growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 12% from 2025 to 2033. This expansion is underpinned by several key market growth drivers, including the exponential increase in genomic data generation, the widespread adoption of personalized medicine, and the escalating demand for rapid and accurate diagnostic testing for infectious diseases and inherited conditions. Technological disruptions are rapidly transforming the landscape; the integration of artificial intelligence (AI) and machine learning (ML) into automation platforms is enabling predictive analytics, optimized workflow management, and enhanced data interpretation. Furthermore, the miniaturization of robotic systems and the development of modular, scalable automation solutions are making these technologies more accessible to a wider range of research institutions and clinical laboratories. Consumer preferences are shifting towards end-to-end automation solutions that minimize manual intervention, reduce the risk of contamination and human error, and significantly improve throughput and turnaround times for complex genomic analyses. Competitive dynamics are intensifying, with companies focusing on developing proprietary software for intelligent workflow management, enhancing interoperability between different automation components, and offering comprehensive service and support packages. The market penetration of advanced automation in genomics is still in its early stages, offering substantial room for growth as the benefits of increased efficiency, reproducibility, and cost-effectiveness become more widely recognized. The increasing focus on translational research and drug discovery is also a major catalyst, as automated platforms can accelerate the screening of potential therapeutic targets and the development of novel treatments. The global market size is estimated to exceed $15 Million by the end of the forecast period.
Dominant Markets & Segments in Lab Automation in Genomics Industry
The Lab Automation in Genomics Industry is significantly influenced by the dominance of specific regions and equipment segments. North America, particularly the United States, currently leads the market, driven by substantial government and private investment in genomics research, a well-established biotechnology sector, and a high adoption rate of advanced technologies. The presence of leading research institutions and pharmaceutical companies further bolsters this dominance. Within the equipment segment, Automated Liquid Handlers command the largest market share, accounting for an estimated 40% of the total market value. These systems are indispensable for critical genomic workflows such as DNA extraction, library preparation for sequencing, and reagent dispensing.
- Leading Region: North America
- Key Drivers:
- Robust government funding for genomics research (e.g., National Institutes of Health initiatives).
- Presence of major pharmaceutical and biotech hubs.
- High adoption of advanced sequencing technologies.
- Strong regulatory support for innovation in healthcare.
- Key Drivers:
- Dominant Equipment Segment: Automated Liquid Handlers
- Detailed Dominance Analysis: Automated liquid handlers are the backbone of genomic sample processing. Their ability to precisely and reproducibly dispense minute volumes of reagents is critical for workflows like PCR, NGS library preparation, and microarrays. The increasing demand for high-throughput screening and the need to minimize human error in these sensitive processes have propelled the market for sophisticated liquid handling platforms. The estimated market size for automated liquid handlers alone is projected to exceed $6 Million by 2033. Their versatility and essential role in almost every genomic assay make them a foundational component of lab automation.
- Other Significant Segments:
- Robotic Arms: Crucial for moving plates, samples, and performing complex manipulations, contributing an estimated 25% to the market.
- Automated Plate Handlers: Facilitate efficient management and transfer of microplates, holding an estimated 20% of the market.
- Automated Storage and Retrieval Systems (AS/RS): Increasingly important for managing large sample libraries and ensuring sample integrity, estimated at 10% of the market.
- Vision Systems: Integral for quality control and process monitoring, representing an estimated 5% of the market.
Lab Automation in Genomics Industry Product Developments
Recent product developments in Lab Automation in Genomics Industry are characterized by increased integration, enhanced software intelligence, and a focus on user-friendliness. Innovations are driving greater efficiency and accuracy in complex genomic workflows. For example, the introduction of AI-powered predictive maintenance in liquid handlers minimizes downtime, while advanced robotic arms offer greater dexterity for intricate sample handling. The integration of vision systems with automated platforms ensures real-time quality control, reducing the risk of failed experiments and wasted resources. These advancements provide significant competitive advantages by enabling researchers to accelerate discovery, improve diagnostic accuracy, and reduce operational costs, making them highly attractive to genomics laboratories worldwide.
Report Scope & Segmentation Analysis
This report meticulously segments the Lab Automation in Genomics Industry into key equipment categories, providing detailed market analysis and growth projections for each.
- Automated Liquid Handlers: This segment is projected to exhibit a CAGR of 13%, reaching an estimated market size of over $6 Million by 2033. These systems are central to sample preparation for NGS, PCR, and other molecular assays, with demand driven by research and diagnostic applications.
- Automated Plate Handlers: Expected to grow at a CAGR of 11%, with a market size projected to exceed $3 Million by 2033. These systems are vital for efficiently managing microplates in high-throughput screening and assay development, supporting increased laboratory throughput.
- Robotic Arms: This segment is anticipated to grow at a CAGR of 12%, reaching a market size of approximately $3.7 Million by 2033. Robotic arms are increasingly employed for complex manipulations, sample transport, and integration with other automation components to create fully automated workflows.
- Automated Storage and Retrieval Systems (AS/RS): Forecasted to grow at a CAGR of 14%, with an estimated market size of over $1.5 Million by 2033. The increasing volume of genomic samples necessitates efficient and secure storage solutions, driving demand for AS/RS in biobanking and sample management.
- Vision Systems: This segment is expected to grow at a CAGR of 10%, reaching an estimated market size of approximately $750,000 by 2033. Vision systems play a crucial role in quality control, error detection, and process monitoring within automated workflows.
Key Drivers of Lab Automation in Genomics Industry Growth
The Lab Automation in Genomics Industry is experiencing significant growth driven by a confluence of factors. The escalating volume of genomic data generated by Next-Generation Sequencing (NGS) necessitates automated solutions for efficient processing and analysis. The burgeoning field of personalized medicine, which relies heavily on individual genomic profiling, further amplifies the demand for high-throughput automation. Regulatory mandates pushing for greater standardization and reproducibility in molecular diagnostics also encourage the adoption of automated platforms. Furthermore, the increasing prevalence of chronic and infectious diseases fuels the need for rapid and accurate genomic testing, where automation plays a pivotal role in reducing turnaround times. Economic factors, such as the desire to reduce operational costs and improve laboratory efficiency, also contribute significantly to the market's expansion.
- Technological Advancements: Integration of AI/ML, robotics, and advanced liquid handling.
- Personalized Medicine: Increasing demand for individual genomic analysis.
- Diagnostic Needs: Growing requirement for rapid and accurate genetic testing.
- Research Funding: Sustained investment in genomics research globally.
Challenges in the Lab Automation in Genomics Industry Sector
Despite the promising growth trajectory, the Lab Automation in Genomics Industry faces several challenges. The high initial cost of sophisticated automation systems can be a significant barrier for smaller laboratories and research institutions. Interoperability issues between different vendors' equipment and software can lead to complex integration challenges, increasing implementation time and costs. The need for specialized personnel with expertise in operating and maintaining these advanced systems also presents a challenge. Furthermore, the evolving regulatory landscape requires continuous validation and compliance efforts for automated workflows, adding to the operational burden. Supply chain disruptions for critical components can also impact production timelines and product availability.
- High Capital Investment: Significant upfront cost of automation systems.
- Integration Complexity: Challenges in ensuring seamless interoperability between different platforms.
- Skilled Workforce Shortage: Demand for trained personnel to operate and maintain equipment.
- Regulatory Compliance: Ongoing validation and adherence to evolving standards.
- Supply Chain Vulnerabilities: Potential disruptions impacting component availability.
Emerging Opportunities in Lab Automation in Genomics Industry
Emerging opportunities in the Lab Automation in Genomics Industry are centered on technological innovation and expanding market applications. The integration of AI and machine learning into automation platforms offers immense potential for intelligent data analysis and predictive workflow optimization, leading to faster scientific discovery. The growing demand for point-of-care genomic testing presents an opportunity for developing more compact and user-friendly automated solutions. Furthermore, the expansion of genomics into new areas like agriculture, environmental science, and forensic analysis opens up novel market segments for automation providers. The increasing focus on rare disease diagnostics and the development of targeted therapies also drives the need for specialized and flexible automation capabilities. Collaboration between automation vendors and genomics software developers will foster the creation of more comprehensive and integrated solutions.
- AI-Driven Workflows: Enhanced data analysis and predictive capabilities.
- Point-of-Care Genomics: Development of compact and accessible automated solutions.
- New Market Applications: Expansion into agriculture, environmental, and forensic genomics.
- Rare Disease Diagnostics: Specialized automation for targeted genetic testing.
- Integrated Solutions: Synergies between hardware and software providers.
Leading Players in the Lab Automation in Genomics Industry Market
- Becton Dickinson and Company
- Tecan Group Ltd
- Synchron Lab Automation
- Perkinelmer Inc
- Thermo Fisher Scientific Inc
- Eli Lilly and Company
- Danaher Corporation / Beckman Coulter
- Siemens Healthineers AG
- Agilent Technologies Inc
- Hudson Robotics Inc
- F Hoffmann-La Roche Ltd
Key Developments in Lab Automation in Genomics Industry Industry
- July 2022: MAKO Medical Laboratories announced to expand molecular and COVID-19 test processing capacity by purchasing four additional high-tech liquid handling automation systems to allow the lab to more than double the COVID-19 testing capacity of a single lab technician in the future.
- July 2022: University Hospital Southampton (UHS) NHS Foundation Trust signed a strategic collaboration agreement with the robotic automation solution provider, Automata, to build new applications for laboratory automation technology.
Strategic Outlook for Lab Automation in Genomics Industry Market
The strategic outlook for the Lab Automation in Genomics Industry is overwhelmingly positive, characterized by sustained growth and evolving technological integration. The increasing demand for personalized medicine and the continuous advancements in genomic sequencing technologies will remain primary growth catalysts. Investment in AI and machine learning will further drive the development of smarter, more autonomous automation systems, enhancing data interpretation and workflow efficiency. The expansion of automated solutions into emerging markets and new application areas, such as clinical diagnostics beyond infectious diseases and drug discovery for rare conditions, presents significant untapped potential. Strategic collaborations between technology providers, research institutions, and pharmaceutical companies will be crucial for developing comprehensive, end-to-end solutions that address the complex needs of the modern genomics laboratory, ultimately accelerating scientific breakthroughs and improving patient outcomes. The market is expected to witness continued consolidation and innovation, with a strong emphasis on scalability, cost-effectiveness, and user-centric design.
Lab Automation in Genomics Industry Segmentation
-
1. Equipment
- 1.1. Automated Liquid Handlers
- 1.2. Automated Plate Handlers
- 1.3. Robotic Arms
- 1.4. Automated Storage and Retrieval Systems (AS/RS)
- 1.5. Vision Systems
Lab Automation in Genomics Industry Segmentation By Geography
- 1. North America
- 2. Europe
- 3. Asia
- 4. Latin America
- 5. Middle East and Africa
Lab Automation in Genomics Industry Regional Market Share
Geographic Coverage of Lab Automation in Genomics Industry
Lab Automation in Genomics Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 12.43% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Research and Development by Pharmaceutical and Biotech Companies; Growing Demand from Drug Discovery and Genomics
- 3.3. Market Restrains
- 3.3.1. Growing Trend of Digital Transformation for Laboratories with IoT; Effective Management of the Huge Amount of Data Generated
- 3.4. Market Trends
- 3.4.1. Automated Liquid Handlers to Witness High Growth
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Lab Automation in Genomics Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Equipment
- 5.1.1. Automated Liquid Handlers
- 5.1.2. Automated Plate Handlers
- 5.1.3. Robotic Arms
- 5.1.4. Automated Storage and Retrieval Systems (AS/RS)
- 5.1.5. Vision Systems
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. North America
- 5.2.2. Europe
- 5.2.3. Asia
- 5.2.4. Latin America
- 5.2.5. Middle East and Africa
- 5.1. Market Analysis, Insights and Forecast - by Equipment
- 6. North America Lab Automation in Genomics Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Equipment
- 6.1.1. Automated Liquid Handlers
- 6.1.2. Automated Plate Handlers
- 6.1.3. Robotic Arms
- 6.1.4. Automated Storage and Retrieval Systems (AS/RS)
- 6.1.5. Vision Systems
- 6.1. Market Analysis, Insights and Forecast - by Equipment
- 7. Europe Lab Automation in Genomics Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Equipment
- 7.1.1. Automated Liquid Handlers
- 7.1.2. Automated Plate Handlers
- 7.1.3. Robotic Arms
- 7.1.4. Automated Storage and Retrieval Systems (AS/RS)
- 7.1.5. Vision Systems
- 7.1. Market Analysis, Insights and Forecast - by Equipment
- 8. Asia Lab Automation in Genomics Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Equipment
- 8.1.1. Automated Liquid Handlers
- 8.1.2. Automated Plate Handlers
- 8.1.3. Robotic Arms
- 8.1.4. Automated Storage and Retrieval Systems (AS/RS)
- 8.1.5. Vision Systems
- 8.1. Market Analysis, Insights and Forecast - by Equipment
- 9. Latin America Lab Automation in Genomics Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Equipment
- 9.1.1. Automated Liquid Handlers
- 9.1.2. Automated Plate Handlers
- 9.1.3. Robotic Arms
- 9.1.4. Automated Storage and Retrieval Systems (AS/RS)
- 9.1.5. Vision Systems
- 9.1. Market Analysis, Insights and Forecast - by Equipment
- 10. Middle East and Africa Lab Automation in Genomics Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Equipment
- 10.1.1. Automated Liquid Handlers
- 10.1.2. Automated Plate Handlers
- 10.1.3. Robotic Arms
- 10.1.4. Automated Storage and Retrieval Systems (AS/RS)
- 10.1.5. Vision Systems
- 10.1. Market Analysis, Insights and Forecast - by Equipment
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Becton Dickinson and Company
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Tecan Group Ltd
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Synchron Lab Automation
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Perkinelmer Inc
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Thermo Fisher Scientific Inc
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Eli Lilly and Company
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Danaher Corporation / Beckman Coulter
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Siemens Healthineers AG
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Agilent Technologies Inc
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Hudson Robotics Inc
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 F Hoffmann-La Roche Ltd *List Not Exhaustive
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: Global Lab Automation in Genomics Industry Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: North America Lab Automation in Genomics Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 3: North America Lab Automation in Genomics Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 4: North America Lab Automation in Genomics Industry Revenue (Million), by Country 2025 & 2033
- Figure 5: North America Lab Automation in Genomics Industry Revenue Share (%), by Country 2025 & 2033
- Figure 6: Europe Lab Automation in Genomics Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 7: Europe Lab Automation in Genomics Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 8: Europe Lab Automation in Genomics Industry Revenue (Million), by Country 2025 & 2033
- Figure 9: Europe Lab Automation in Genomics Industry Revenue Share (%), by Country 2025 & 2033
- Figure 10: Asia Lab Automation in Genomics Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 11: Asia Lab Automation in Genomics Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 12: Asia Lab Automation in Genomics Industry Revenue (Million), by Country 2025 & 2033
- Figure 13: Asia Lab Automation in Genomics Industry Revenue Share (%), by Country 2025 & 2033
- Figure 14: Latin America Lab Automation in Genomics Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 15: Latin America Lab Automation in Genomics Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 16: Latin America Lab Automation in Genomics Industry Revenue (Million), by Country 2025 & 2033
- Figure 17: Latin America Lab Automation in Genomics Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: Middle East and Africa Lab Automation in Genomics Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 19: Middle East and Africa Lab Automation in Genomics Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 20: Middle East and Africa Lab Automation in Genomics Industry Revenue (Million), by Country 2025 & 2033
- Figure 21: Middle East and Africa Lab Automation in Genomics Industry Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 2: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Region 2020 & 2033
- Table 3: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 4: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 5: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 6: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 7: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 8: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 9: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 10: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 11: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 12: Global Lab Automation in Genomics Industry Revenue Million Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Lab Automation in Genomics Industry?
The projected CAGR is approximately 12.43%.
2. Which companies are prominent players in the Lab Automation in Genomics Industry?
Key companies in the market include Becton Dickinson and Company, Tecan Group Ltd, Synchron Lab Automation, Perkinelmer Inc, Thermo Fisher Scientific Inc, Eli Lilly and Company, Danaher Corporation / Beckman Coulter, Siemens Healthineers AG, Agilent Technologies Inc, Hudson Robotics Inc, F Hoffmann-La Roche Ltd *List Not Exhaustive.
3. What are the main segments of the Lab Automation in Genomics Industry?
The market segments include Equipment.
4. Can you provide details about the market size?
The market size is estimated to be USD 2.12 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Research and Development by Pharmaceutical and Biotech Companies; Growing Demand from Drug Discovery and Genomics.
6. What are the notable trends driving market growth?
Automated Liquid Handlers to Witness High Growth.
7. Are there any restraints impacting market growth?
Growing Trend of Digital Transformation for Laboratories with IoT; Effective Management of the Huge Amount of Data Generated.
8. Can you provide examples of recent developments in the market?
July 2022: MAKO Medical Laboratories announced to expand molecular and COVID-19 test processing capacity by purchasing four additional high-tech liquid handling automation systems to allow the lab to more than double the COVID-19 testing capacity of a single lab technician in the future.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Lab Automation in Genomics Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Lab Automation in Genomics Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Lab Automation in Genomics Industry?
To stay informed about further developments, trends, and reports in the Lab Automation in Genomics Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence